Targeting NLRP3 significantly reduces physical, biochemical, and molecular markers associated with diabetic nephropathy, providing protection from high glucose-induced glomerular injury, changes which initiate progression of kidney injury in both T1DM and T2DM. The gene discussed is NLRP3; the disease is diabetic kidney disease.